The addition of the AKT inhibitor capivasertib (Truqap) to abiraterone (Zytiga) and androgen deprivation therapy (ADT) ...

Levodopa—the gold-standard treatment for Parkinson's disease—increases dopamine in the brain. But as the disease progresses ...

The tumor begins before birth. Somewhere in the developing fetus, neural crest cells that should have matured into adrenal tissue or sympathetic ganglia take a wrong turn, and a child is born ...

The phase 2 ASSIST trial showed that atrasentan has an additional antiproteinuric effect -- approximately 25% -- over 12 weeks in patients with earlier-stage IgA nephropathy already receiving ...

Booster or add-on medications can help your antidepressant work better. Learn affordable ways to enhance your treatment.

Add Yahoo as a preferred source to see more of our stories on Google. The US Food and Drug Administration selected enlicitide to receive the Commissioner’s National Priority Voucher (CNPV) in December ...

The pooled overall survival estimate for six phase 3 trials favored PD-1/PD-L1 inhibitor plus platinum-etoposide over platinum-etoposide alone In the treatment of extensive-stage small-cell lung ...

Investigators suggest LDL targets typically reserved for secondary prevention are best in high-risk patients with diabetes.

Final analysis from the phase 2 OVATION 2 trial (NCT03393884) has demonstrated a continued and growing overall survival (OS) advantage with IMNN-001 plus standard-of-care (SOC) neoadjuvant and ...

This is a syndicated post stub. Clinical Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical ...

The 7 mg dose of OV329 demonstrated favorable safety and tolerability profile, reinforcing best-in-category potential for refractory epilepsies; ...